To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrs
Conditions: Hepatitis A; Hep A Interventions: Biological: Boryung Hepatitis A Vaccine Pre-Filled Syringe Inj. 0.5 mL; Biological: HAVRIX 720 Junior 0.5 mL Sponsor: Boryung Biopharma Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2022 Category: Research Source Type: clinical trials